185 related articles for article (PubMed ID: 29185849)
1. RAS ubiquitylation modulates effector interactions.
Thurman R; Siraliev-Perez E; Campbell SL
Small GTPases; 2020 May; 11(3):180-185. PubMed ID: 29185849
[TBL] [Abstract][Full Text] [Related]
2. A KRAS GTPase K104Q Mutant Retains Downstream Signaling by Offsetting Defects in Regulation.
Yin G; Kistler S; George SD; Kuhlmann N; Garvey L; Huynh M; Bagni RK; Lammers M; Der CJ; Campbell SL
J Biol Chem; 2017 Mar; 292(11):4446-4456. PubMed ID: 28154176
[TBL] [Abstract][Full Text] [Related]
3. Raf-1 is involved in the regulation of the interaction between guanine nucleotide exchange factor and Ha-ras. Evidences for a function of Raf-1 and phosphatidylinositol 3-kinase upstream to Ras.
Giglione C; Parmeggiani A
J Biol Chem; 1998 Dec; 273(52):34737-44. PubMed ID: 9856997
[TBL] [Abstract][Full Text] [Related]
4. A new function of p120-GTPase-activating protein. Prevention of the guanine nucleotide exchange factor-stimulated nucleotide exchange on the active form of Ha-ras p21.
Giglione C; Parrini MC; Baouz S; Bernardi A; Parmeggiani A
J Biol Chem; 1997 Oct; 272(40):25128-34. PubMed ID: 9312123
[TBL] [Abstract][Full Text] [Related]
5. Peptides containing a consensus Ras binding sequence from Raf-1 and theGTPase activating protein NF1 inhibit Ras function.
Clark GJ; Drugan JK; Terrell RS; Bradham C; Der CJ; Bell RM; Campbell S
Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1577-81. PubMed ID: 8643674
[TBL] [Abstract][Full Text] [Related]
6. Oncogenic and RASopathy-associated K-RAS mutations relieve membrane-dependent occlusion of the effector-binding site.
Mazhab-Jafari MT; Marshall CB; Smith MJ; Gasmi-Seabrook GM; Stathopulos PB; Inagaki F; Kay LE; Neel BG; Ikura M
Proc Natl Acad Sci U S A; 2015 May; 112(21):6625-30. PubMed ID: 25941399
[TBL] [Abstract][Full Text] [Related]
7. GTP Binding and Oncogenic Mutations May Attenuate Hypervariable Region (HVR)-Catalytic Domain Interactions in Small GTPase K-Ras4B, Exposing the Effector Binding Site.
Lu S; Banerjee A; Jang H; Zhang J; Gaponenko V; Nussinov R
J Biol Chem; 2015 Nov; 290(48):28887-900. PubMed ID: 26453300
[TBL] [Abstract][Full Text] [Related]
8. Ubiquitination of K-Ras enhances activation and facilitates binding to select downstream effectors.
Sasaki AT; Carracedo A; Locasale JW; Anastasiou D; Takeuchi K; Kahoud ER; Haviv S; Asara JM; Pandolfi PP; Cantley LC
Sci Signal; 2011 Mar; 4(163):ra13. PubMed ID: 21386094
[TBL] [Abstract][Full Text] [Related]
9. A synthetic peptide corresponding to a sequence in the GTPase activating protein inhibits p21ras stimulation and promotes guanine nucleotide exchange.
Rubinfeld B; Wong G; Bekesi E; Wood A; Heimer E; McCormick F; Polakis P
Int J Pept Protein Res; 1991 Jul; 38(1):47-53. PubMed ID: 1938104
[TBL] [Abstract][Full Text] [Related]
10. The molecular basis for immune dysregulation by the hyperactivated E62K mutant of the GTPase RAC2.
Arrington ME; Temple B; Schaefer A; Campbell SL
J Biol Chem; 2020 Aug; 295(34):12130-12142. PubMed ID: 32636302
[TBL] [Abstract][Full Text] [Related]
11. Guanine-nucleotide binding activity, interaction with GTPase-activating protein and solution conformation of the human c-Ha-Ras protein catalytic domain are retained upon deletion of C-terminal 18 amino acid residues.
Fujita-Yoshigaki J; Ito Y; Yamasaki K; Muto Y; Miyazawa T; Nishimura S; Yokoyama S
J Protein Chem; 1992 Dec; 11(6):731-9. PubMed ID: 1466766
[TBL] [Abstract][Full Text] [Related]
12. Post-translational modifications of Ras and Ral are important for the action of Ral GDP dissociation stimulator.
Hinoi T; Kishida S; Koyama S; Ikeda M; Matsuura Y; Kikuchi A
J Biol Chem; 1996 Aug; 271(33):19710-6. PubMed ID: 8702675
[TBL] [Abstract][Full Text] [Related]
13. Direct inhibition of oncogenic KRAS by Bacillus pumilus ribonuclease (binase).
Ilinskaya ON; Singh I; Dudkina E; Ulyanova V; Kayumov A; Barreto G
Biochim Biophys Acta; 2016 Jul; 1863(7 Pt A):1559-67. PubMed ID: 27066977
[TBL] [Abstract][Full Text] [Related]
14. Improved binding of raf to Ras.GDP is correlated with biological activity.
Kiel C; Filchtinski D; Spoerner M; Schreiber G; Kalbitzer HR; Herrmann C
J Biol Chem; 2009 Nov; 284(46):31893-902. PubMed ID: 19776012
[TBL] [Abstract][Full Text] [Related]
15. Multivalent assembly of KRAS with the RAS-binding and cysteine-rich domains of CRAF on the membrane.
Fang Z; Lee KY; Huo KG; Gasmi-Seabrook G; Zheng L; Moghal N; Tsao MS; Ikura M; Marshall CB
Proc Natl Acad Sci U S A; 2020 Jun; 117(22):12101-12108. PubMed ID: 32414921
[TBL] [Abstract][Full Text] [Related]
16. Different structural requirements within the switch II region of the Ras protein for interactions with specific downstream targets.
Moodie SA; Paris M; Villafranca E; Kirshmeier P; Willumsen BM; Wolfman A
Oncogene; 1995 Aug; 11(3):447-54. PubMed ID: 7630628
[TBL] [Abstract][Full Text] [Related]
17. ralGDS family members interact with the effector loop of ras p21.
Kikuchi A; Demo SD; Ye ZH; Chen YW; Williams LT
Mol Cell Biol; 1994 Nov; 14(11):7483-91. PubMed ID: 7935463
[TBL] [Abstract][Full Text] [Related]
18. The differential effects of the Gly-60 to Ala mutation on the interaction of H-Ras p21 with different downstream targets.
Hwang MC; Sung YJ; Hwang YW
J Biol Chem; 1996 Apr; 271(14):8196-202. PubMed ID: 8626511
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the average structures, from molecular dynamics, of complexes of GTPase activating protein (GAP) with oncogenic and wild-type ras-p21: identification of potential effector domains.
Chen JM; Friedman FK; Brandt-Rauf PW; Pincus MR; Chie L
J Protein Chem; 2002 Jul; 21(5):349-59. PubMed ID: 12206509
[TBL] [Abstract][Full Text] [Related]
20. TC21 causes transformation by Raf-independent signaling pathways.
Graham SM; Vojtek AB; Huff SY; Cox AD; Clark GJ; Cooper JA; Der CJ
Mol Cell Biol; 1996 Nov; 16(11):6132-40. PubMed ID: 8887643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
